Red Blood Cells Parameters Highlights Glioblastoma Patients Subgroup With Improved Median Overall Survival

Tehila Kaisman-Elbaz^{1, 2}, Yonatan Elbaz³, Vladimir Merkin¹, Lianne Dym², Ariel Noy², Maya Atar-Vardi2, Romi Bari⁴, Konstantin Lavrenkov⁵, Israel Melamed¹
1. Dept. of Neurosurgery, Soroka University Medical Center, Be'er Sheva, 2. Faculty of Health Sciences, Ben Gurion University of the Negev, Be'er Sheva, 3. Dept. of Physics, Negev Nuclear Research Center, Dimona, 4. Clinical Research Center, Soroka University Medical Center, Be'er Sheva, 5. Institute of Oncology, Soroka University Medical Center, Be'er Sheva, Israel

The Prognostic Value of Pretreatment Neutrophil/Lymphocyte Ratio in Patients with Glioblastoma: A Retrospective Cohort Study of Patients Treated with Surgery and Stupp Protocol

Agam Brenner^{1, 2}, Michael Friger³, David B. Geffen^{1, 2}, Tehila Kaisman-Elbaz^{2, 4}, Konstantin Lavrenkov^{1, 2}
1. Dept. of Oncology, Soroka University Medical Center, Be'er Sheva, 2.Faculty of Health Sciences, Ben Gurion University of the Negev, Be'er Sheva, 3. Dept. of Public Health, Faculty of Health Sciences, Ben Gurion University of the Negev, Be'er Sheva, 4. Dept. of Neurosurgery, Soroka University Medical Center, Be'er Sheva, Israel